Recent progress in TGF-β inhibitors for cancer therapy
Zheng‐Yi Huang(National Sun Yat-sen University), Chun‐Lin Chen(Guizhou University), Jih‐Jung Chen(National Yang Ming Chiao Tung University), Pei‐Feng Liu(National Sun Yat-sen University), Chih-Ling Chung(National Sun Yat-sen University), Tsung‐Hui Hu(National Sun Yat-sen University)
Cited by 197
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217